These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 980740)

  • 1. [Apparent cure with a progestagen of endometrial cancer with pulmonary metastases].
    Legrand M; Eukirch
    Nouv Presse Med; 1976 Oct; 5(32):2086. PubMed ID: 980740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone].
    Stamm H; De Grandi P
    Rev Med Suisse Romande; 1981 Nov; 101(11):913-7. PubMed ID: 7323568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant responses to progestin in a patient with uterine low-grade smooth-muscle tumors metastatic to the lung.
    Lo CA; Huang SC; Ho CL; Tzeng CC; Chou CY; Hsu KF
    J Obstet Gynaecol Res; 2005 Oct; 31(5):394-8. PubMed ID: 16176506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of progestational agents in endometrial adenocarcinoma.
    Rozier JC; Underwood PB
    Obstet Gynecol; 1974 Jul; 44(1):60-4. PubMed ID: 4834800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic lung tumor from uterine leiomyosarcoma].
    Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
    Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy.
    Wilkinson EJ; Friedrich EG; Mattingly RF; Regali JA; Garancis JC
    Obstet Gynecol; 1973 Aug; 42(2):193-200. PubMed ID: 4721406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body].
    Takeda M; Kubo K; Fukushima M; Hirayama J; Sekiguchi M
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2113-7. PubMed ID: 2145808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
    Bonte J; Drochmans A; Ide P
    Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
    Bernardo-Strada MR; Imparato E; Aspesi G; Pavesi L; Robustelli Della Cuna G
    Minerva Med; 1980 Nov; 71(44):3241-6. PubMed ID: 7454090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
    Piver MS; Lele S; Barlow JJ
    Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of so-called benign metastasizing leiomyoma responsive to progesterone].
    Motegi M; Takayanagi N; Sando Y; Ubukata M; Imai S; Suzuki T; Nakajima T; Yoshida I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):890-5. PubMed ID: 8366630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
    Stertmann WA; Hocke M; Röttger P
    MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
    [No Abstract]   [Full Text] [Related]  

  • 19. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
    Paine CH; Wright FW; Ellis F
    Br J Cancer; 1970 Jun; 24(2):277-82. PubMed ID: 5451569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.